These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7565547)

  • 21. Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Masur H; Holmes KK; Kaplan JE
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S1-4. PubMed ID: 10770910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USPHS and IDSA collaborate on guidelines to prevent opportunistic infections in HIV-infected persons.
    Kaplan JE; Holmes KK
    Emerg Infect Dis; 1995; 1(3):102-3. PubMed ID: 8903176
    [No Abstract]   [Full Text] [Related]  

  • 23. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part III. Prevention of disease recurrence. United States Public Health Service/Infectious Diseases Society of America.
    Am Fam Physician; 2000 Feb; 61(3):771-8, 780, 785. PubMed ID: 10695588
    [No Abstract]   [Full Text] [Related]  

  • 24. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part III. Prevention of disease recurrence. U.S. Department of Health and Human Services, Public Health Service. Centers for Disease Control and Prevention.
    Am Fam Physician; 1997 Oct; 56(5):1387-92. PubMed ID: 9337761
    [No Abstract]   [Full Text] [Related]  

  • 25. 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part I. Prevention of Exposure.
    Am Fam Physician; 2000 Jan; 61(1):163-74. PubMed ID: 10643957
    [No Abstract]   [Full Text] [Related]  

  • 26. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part II. Prevention of the first episode of disease. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. U.S. Public Health Service/Infectious Diseases Society of America.
    Am Fam Physician; 2000 Jan; 61(2):441-2, 445-9, 453-4 passim. PubMed ID: 10670509
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiretroviral therapy and medical management of pediatric HIV infection and 1997 USPHS/IDSA report on the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Pediatrics; 1998 Oct; 102(4 Pt 2):999-1085. PubMed ID: 9826994
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection.
    Kovacs JA; Masur H
    N Engl J Med; 2000 May; 342(19):1416-29. PubMed ID: 10805828
    [No Abstract]   [Full Text] [Related]  

  • 30. Discontinuation of prophylaxis in HAART-responders.
    Maenza J
    Hopkins HIV Rep; 1999 Jul; 11(4):2-3. PubMed ID: 11366923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.
    Cheever LW; Chaisson RE; Gallant JE
    West J Med; 1996; 165(1-2):67-73. PubMed ID: 8855697
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of prophylaxis against invasive pneumococcal infections in human immunodeficiency virus-infected children.
    Peters VB; Hyatt AC; Schechter C; Diamant EP; Hodes DS
    Pediatr Infect Dis J; 1994 Jul; 13(7):667-9. PubMed ID: 7970963
    [No Abstract]   [Full Text] [Related]  

  • 33. Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.
    Siberry GK; Abzug MJ; Nachman S;
    Pediatr Infect Dis J; 2013 Dec; 32(12):1303-7. PubMed ID: 24569304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.
    Gross PA; Asch S; Kitahata MM; Freedberg KA; Barr D; Melnick DA; Bozzette SA
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S85-93. PubMed ID: 10770917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis against opportunistic infections in persons infected with human immunodeficiency virus.
    Martin JE; Besch CL; ;
    Am J Med Sci; 2004 Jul; 328(1):64-9. PubMed ID: 15254443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
    MMWR Recomm Rep; 1993 Jun; 42(RR-9):14-20. PubMed ID: 8393134
    [No Abstract]   [Full Text] [Related]  

  • 38. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.
    Benson CA; Kaplan JE; Masur H; Pau A; Holmes KK; ; ;
    MMWR Recomm Rep; 2004 Dec; 53(RR-15):1-112. PubMed ID: 15841069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.
    Yazdanpanah Y; Goldie SJ; Paltiel AD; Losina E; Coudeville L; Weinstein MC; Gerard Y; Kimmel AD; Zhang H; Salamon R; Mouton Y; Freedberg KA
    Clin Infect Dis; 2003 Jan; 36(1):86-96. PubMed ID: 12491207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV infection and AIDS in urology].
    Fischer C; Miller J; Gahr M; Ringert RH
    Urologe A; 1994 May; 33(3):224-31. PubMed ID: 8053091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.